Human Vaccines Market Booming With New Growth Opportunities

Human Vaccines Market

Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. An extremely low risk of serious and fatal side effects associated with vaccines and growing awareness regarding vaccination by various government and non-profit organizations are the key factors driving the human vaccines market.

The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. Extensive promotion and marketing strategies and favorable government support are likely to boost market growth.

Conjugates Dominate Human Vaccines Market by Type

On basis of vaccine type, the conjugate vaccines segment accounted for the majority share in the global human vaccines market in 2015. Prevnar, manufactured by Pfizer, Inc., is a conjugate vaccine, which generated a significant revenue of US$6.2 bn globally in 2015 alone. This is a key factor contributing to the dominance of conjugates in the human vaccine market. However, the growing preference for commercial brands available in the market is likely to drive the combination vaccines segment.

The pneumococcal segment accounted for the majority share in the global human vaccines market by product. A large number of products are commercially available in the market and the prevalence of pneumonia is high across several regions. These factors have been known to drive the pneumococcal segment.

By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Factors such as the high prevalence of pneumonia and polio among children across the world are likely to fuel this segment. On the other hand, adult vaccines are expected to expand at the highest CAGR from 2016 to 2024.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16127

By distribution channel, the hospital pharmacies segment accounted for the lion’s share in the global human vaccines market. However, the drugstores segment is projected to expand at a considerable CAGR during the forecast period owing to a dramatically increasing vaccination rate in standalone pharmacies in the U.S.

Major players operating in the global human vaccines market include AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer, Inc., Sanofi, and Johnson & Johnson.

Posted in
Pragati Pathrotkar

Pragati Pathrotkar

Pragati Pathrotkar is a specialist in search engine optimized (SEO) content with a wealth of experience gathered from working in leading market research firms. Currently, she is the Team Lead for the SEO department at Transparency Market Research. In the said role, she has actively contributed to building a winning content strategy leveraging right keywords, link building, market research and analysis, and competitor analysis. Pragati has a Bachelor’s Degree in Computer Science from Nagpur University and a Master’s degree in Business Administration.

Leave a Reply